{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-140267","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.944751+00:00","generated_at":"2026-05-15T07:47:21.798821+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"Plus Therapeutics approves 1-for-25 reverse stock split to meet Nasdaq $1.00 minimum bid price","bullets":["Reverse split at 1-for-25, effective 12:01 a.m. ET on April 2, 2026; shares drop from ~171.6M to ~6.86M.","Action taken to increase per-share price above Nasdaq's $1.00 minimum bid requirement for continued listing.","No fractional shares issued; cash in lieu; new CUSIP 72941H806; trading symbol stays PSTV.","Broadridge acts as exchange agent; book-entry holders need no action; certificates receive instructions.","Par value unchanged at $0.001; proportional adjustments to equity awards and warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-140267","json":"https://secwatch.observer/filing/0001193125-26-140267.json","markdown":"https://secwatch.observer/filing/0001193125-26-140267.md","text":"https://secwatch.observer/filing/0001193125-26-140267.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/0001193125-26-140267-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312526140267/pstv-20260401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:47:21.798821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}